Ratings by Stifel (Dae Gon Ha)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/24/2026 | Fulcrum Therapeutics | FULC | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2025 | Fulcrum Therapeutics | FULC | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2024 | Editas Medicine | EDIT | Downgrade | Hold (Buy) |
1.99 (2.00) |
0.5% | Details | |
| 11/13/2024 | Prime Medicine | PRME | Maintain | Hold (N/A) |
|
Details | ||
| 11/12/2024 | Mirum Pharamceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2024 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2024 | Editas Medicine | EDIT | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2024 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (Buy) |
|
Details | ||
| 10/1/2024 | Krystal Biotech | KRYS | Maintain | Buy (Buy) |
|
Details | ||
| 9/30/2024 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2024 | Fulcrum Therapeutics | FULC | Downgrade | Hold (Buy) |
8.85 (8.17) |
-7.68% | Details | |
| 9/12/2024 | Inozyme Pharma Inc. | INZY | New Coverage | Buy (N/A) |
5.26 (4.00) |
-23.95% | Details | |
| 9/11/2024 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2024 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 8/28/2024 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2024 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2024 | Mirum Pharamceuticals | MIRM | Maintain | Buy (Buy) |
|
Details | ||
| 7/8/2024 | Amicus Therapeutics | FOLD | Maintain | Buy (Buy) |
|
Details | ||
| 6/24/2024 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2024 | Mirum Pharamceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 5/31/2024 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 5/30/2024 | Abeona Therapeutics | ABEO | New Coverage | Buy (N/A) |
4.10 (4.51) |
10% | Details | |
| 5/13/2024 | Fulcrum Therapeutics | FULC | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2024 | Mirum Pharamceuticals | MIRM | New Coverage | Buy (N/A) |
23.91 (59.97) |
150.82% | Details | |
| 4/15/2024 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 4/15/2024 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2024 | Verve Therapeutics | VERV | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2024 | Soleno Therapeutics Inc. | SLNO | New Coverage | Buy (N/A) |
47.01 (44.44) |
-5.47% | Details | |
| 1/16/2024 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 1/16/2024 | Prime Medicine | PRME | Downgrade | Hold (Buy) |
8.15 (4.01) |
-50.8% | Details | |
| 1/8/2024 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 10/5/2023 | Orchard Therapeutics | ORTX | Downgrade | Hold (Buy) |
8.14 (16.70) |
105.16% | Details | |
| 9/29/2023 | Editas Medicine | EDIT | Upgrade | Buy (Hold) |
7.11 (1.99) |
-72.01% | Details | |
| 9/28/2023 | Amicus Therapeutics | FOLD | Maintain | Buy (N/A) |
|
Details | ||
| 8/22/2023 | Fulcrum Therapeutics | FULC | Upgrade | Buy (Hold) |
3.92 (8.85) |
125.77% | Details | |
| 8/15/2023 | Freeline | FRLN | Maintain | Hold (N/A) |
|
Details | ||
| 8/10/2023 | Rocket Pharmaceuticals | RCKT | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2023 | Rhythm Pharmaceuticals | RYTM | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2023 | Freeline | FRLN | New Coverage | Hold (N/A) |
2.50 (6.48) |
159.2% | Details | |
| 5/23/2023 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2023 | Rhythm Pharmaceuticals | RYTM | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2023 | Prime Medicine | PRME | New Coverage | Buy (N/A) |
13.39 (4.01) |
-70.05% | Details | |
| 4/18/2023 | Krystal Biotech | KRYS | New Coverage | Buy (N/A) |
86.38 (253.69) |
193.69% | Details | |
| 4/5/2023 | Freeline | FRLN | Downgrade | Hold (Buy) |
0.47 (6.48) |
1278.72% | Details | |
| 3/24/2023 | Equillium | EQ | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2023 | Orchard Therapeutics | ORTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2023 | Homology Medicines | FIXX | Maintain | Hold (N/A) |
|
Details | ||
| 3/9/2023 | Fulcrum Therapeutics | FULC | Downgrade | Hold (Buy) |
6.26 (8.17) |
30.51% | Details | |
| 3/2/2023 | Rhythm Pharmaceuticals | RYTM | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2023 | Rocket Pharmaceuticals | RCKT | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2023 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 1/17/2023 | Amicus Therapeutics | FOLD | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2023 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2022 | Orchard Therapeutics | ORTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2022 | Editas Medicine | EDIT | Maintain | Hold (N/A) |
|
Details | ||
| 11/15/2022 | Surrozen Inc. | SRZN | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2022 | Amicus Therapeutics | FOLD | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2022 | Applied Genetic Technologies Corp. | AGTC | Downgrade | Hold (Buy) |
0.24 (0.39) |
62.5% | Details | |
| 10/20/2022 | Fulcrum Therapeutics | FULC | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2022 | Applied Genetic Technologies Corp. | AGTC | Maintain | Buy (N/A) |
|
Details | ||
| 8/24/2022 | Verve Therapeutics | VERV | Upgrade | Buy (Hold) |
36.77 (11.13) |
-69.73% | Details | |
| 8/10/2022 | ChemoCentryx | CCXI | Downgrade | Hold (Buy) |
50.89 (10.16) |
-80.04% | Details | |
| 7/29/2022 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2022 | Rocket Pharmaceuticals | RCKT | Maintain | Buy (Buy) |
|
Details | ||
| 7/19/2022 | Rhythm Pharmaceuticals | RYTM | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2022 | Ultragenyx Pharma | RARE | Maintain | Buy (Buy) |
|
Details | ||
| 7/12/2022 | Rhythm Pharmaceuticals | RYTM | Maintain | Buy (Buy) |
|
Details | ||
| 7/12/2022 | Fulcrum Therapeutics | FULC | Maintain | Buy (Buy) |
|
Details | ||
| 7/1/2022 | Ultragenyx Pharma | RARE | Maintain | Buy (Buy) |
|
Details | ||
| 6/17/2022 | Rhythm Pharmaceuticals | RYTM | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2022 | Orchard Therapeutics | ORTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/27/2022 | Fulcrum Therapeutics | FULC | Maintain | Buy (Buy) |
|
Details | ||
| 5/19/2022 | Rocket Pharmaceuticals | RCKT | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2022 | Homology Medicines | FIXX | Maintain | Hold (Hold) |
|
Details | ||
| 5/13/2022 | Equillium | EQ | Maintain | Buy (Buy) |
|
Details | ||
| 5/4/2022 | Editas Medicine | EDIT | Maintain | Hold (N/A) |
|
Details | ||
| 4/14/2022 | Applied Genetic Technologies Corp. | AGTC | Maintain | Buy (Buy) |
|
Details | ||
| 4/12/2022 | Fulcrum Therapeutics | FULC | Maintain | Buy (Buy) |
|
Details | ||
| 4/4/2022 | Freeline | FRLN | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2022 | Orchard Therapeutics | ORTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2022 | Fulcrum Therapeutics | FULC | Maintain | Buy (Buy) |
|
Details | ||
| 3/25/2022 | Equillium | EQ | Maintain | Buy (Buy) |
|
Details | ||
| 3/24/2022 | Fulcrum Therapeutics | FULC | Maintain | Buy (Buy) |
|
Details | ||
| 3/24/2022 | Freeline | FRLN | Maintain | Buy (Buy) |
|
Details | ||
| 3/24/2022 | Homology Medicines | FIXX | Maintain | Hold (Hold) |
|
Details | ||
| 3/17/2022 | Avrobio Inc. | AVRO | Maintain | Hold (Hold) |
|
Details | ||
| 3/16/2022 | ChemoCentryx | CCXI | Maintain | Buy (Buy) |
|
Details | ||
| 3/14/2022 | Verve Therapeutics | VERV | Maintain | Hold (N/A) |
|
Details | ||
| 3/4/2022 | Applied Genetic Technologies Corp. | AGTC | Maintain | Buy (Buy) |
|
Details | ||
| 3/3/2022 | Fulcrum Therapeutics | FULC | Maintain | Buy (Buy) |
|
Details | ||
| 3/3/2022 | ChemoCentryx | CCXI | Maintain | Buy (Buy) |
|
Details | ||
| 3/2/2022 | Rhythm Pharmaceuticals | RYTM | New Coverage | Buy (N/A) |
8.49 (53.22) |
526.86% | Details | |
| 2/25/2022 | Editas Medicine | EDIT | Maintain | Hold (N/A) |
|
Details | ||
| 2/24/2022 | Amicus Therapeutics | FOLD | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2022 | Equillium | EQ | Maintain | Buy (Buy) |
|
Details | ||
| 2/14/2022 | Applied Genetic Technologies Corp. | AGTC | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2022 | Orchard Therapeutics | ORTX | Maintain | Buy (Buy) |
|
Details | ||
| 2/11/2022 | Freeline | FRLN | Maintain | Buy (Buy) |
|
Details | ||
| 2/11/2022 | ProQR Therapeutics N.V. | PRQR | Downgrade | Hold (Buy) |
5.64 (1.78) |
-68.44% | Details | |
| 2/11/2022 | ProQR Therapeutics N.V. | PRQR | Downgrade | Hold (Buy) |
5.64 (5.64) |
0% | Details | |
| 2/11/2022 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (Buy) |
|
Details | ||
| 2/11/2022 | Ultragenyx Pharma | RARE | Maintain | Buy (Buy) |
|
Details | ||
| 2/11/2022 | Homology Medicines | FIXX | Maintain | Hold (Hold) |
|
Details | ||
| 2/10/2022 | Fulcrum Therapeutics | FULC | Maintain | Buy (Buy) |
|
Details | ||
| 2/8/2022 | Applied Genetic Technologies Corp. | AGTC | Maintain | Buy (Buy) |
|
Details | ||
| 2/8/2022 | Editas Medicine | EDIT | Maintain | Hold (Hold) |
|
Details | ||
| 2/4/2022 | Orchard Therapeutics | ORTX | Maintain | Buy (Buy) |
|
Details | ||
| 2/3/2022 | Intellia Therapeutics | NTLA | Maintain | Buy (Buy) |
|
Details | ||
| 1/19/2022 | ChemoCentryx | CCXI | Maintain | Buy (Buy) |
|
Details | ||
| 1/13/2022 | Editas Medicine | EDIT | Maintain | Hold (Hold) |
|
Details | ||
| 1/12/2022 | Equillium | EQ | Maintain | Buy (Buy) |
|
Details | ||
| 1/12/2022 | Applied Genetic Technologies Corp. | AGTC | Maintain | Buy (Buy) |
|
Details | ||
| 1/12/2022 | ChemoCentryx | CCXI | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2022 | Verve Therapeutics | VERV | Maintain | Hold (Hold) |
|
Details | ||
| 1/4/2022 | Avrobio Inc. | AVRO | Maintain | Hold (N/A) |
|
Details | ||
| 12/17/2021 | Freeline | FRLN | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2021 | Fulcrum Therapeutics | FULC | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2021 | Amicus Therapeutics | FOLD | Upgrade | Buy (Hold) |
11.68 (14.34) |
22.77% | Details | |
| 10/29/2021 | Equillium | EQ | New Coverage | Buy (N/A) |
5.89 (1.85) |
-68.59% | Details | |
| 10/8/2021 | ChemoCentryx | CCXI | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2021 | Editas Medicine | EDIT | Maintain | Hold (N/A) |
|
Details | ||
| 9/29/2021 | Editas Medicine | EDIT | Maintain | Hold (N/A) |
|
Details | ||
| 9/24/2021 | Applied Genetic Technologies Corp. | AGTC | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2021 | Editas Medicine | EDIT | New Coverage | Hold (N/A) |
59.11 (2.00) |
-96.62% | Details | |
| 9/24/2021 | Verve Therapeutics | VERV | New Coverage | Hold (N/A) |
47.02 (36.77) |
-21.8% | Details | |
| 9/24/2021 | Intellia Therapeutics | NTLA | New Coverage | Buy (N/A) |
149.05 (13.44) |
-90.98% | Details | |
| 9/7/2021 | Surrozen Inc. | SRZN | New Coverage | Buy (N/A) |
6.98 (27.04) |
287.39% | Details | |
| 8/10/2021 | Fulcrum Therapeutics | FULC | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2021 | Avrobio Inc. | AVRO | Maintain | Hold (N/A) |
|
Details | ||
| 8/3/2021 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2021 | Fulcrum Therapeutics | FULC | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2021 | ChemoCentryx | CCXI | Upgrade | Buy (Hold) |
13.18 (10.16) |
-22.91% | Details | |
| 6/24/2021 | Fulcrum Therapeutics | FULC | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2021 | Freeline | FRLN | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2021 | Avrobio Inc. | AVRO | Maintain | Hold (N/A) |
|
Details | ||
| 5/11/2021 | Rocket Pharmaceuticals | RCKT | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2021 | Fulcrum Therapeutics | FULC | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2021 | ChemoCentryx | CCXI | Downgrade | Hold (Buy) |
27.49 (13.18) |
-52.06% | Details | |
| 5/4/2021 | Applied Genetic Technologies Corp. | AGTC | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2021 | Avrobio Inc. | AVRO | Maintain | Hold (N/A) |
|
Details | ||
| 5/3/2021 | ProQR Therapeutics N.V. | PRQR | New Coverage | Buy (N/A) |
6.22 (5.64) |
-9.32% | Details | |
| 3/24/2021 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | Fulcrrum Therapeutics | FULC | New Coverage | Buy (N/A) |
12.61 (8.17) |
-35.21% | Details | |
| 3/2/2021 | Amicus Therapeutics | FOLD | New Coverage | Hold (N/A) |
12.28 (14.34) |
16.78% | Details | |
| 3/2/2021 | Freeline | FRLN | New Coverage | Buy (N/A) |
14.91 (0.47) |
-96.85% | Details | |
| 3/2/2021 | Orchard Therapeutics | ORTX | New Coverage | Buy (N/A) |
6.97 (8.14) |
16.79% | Details | |
| 3/2/2021 | Avrobio Inc. | AVRO | New Coverage | Hold (N/A) |
11.00 (1.40) |
-87.27% | Details | |
| 3/2/2021 | Homology Medicines | FIXX | New Coverage | Hold (N/A) |
10.74 (0.93) |
-91.34% | Details | |
| 3/2/2021 | Applied Genetic Technologies Corp. | AGTC | New Coverage | Buy (N/A) |
5.08 (0.39) |
-92.32% | Details | |
| 3/2/2021 | Rocket Pharmaceuticals | RCKT | New Coverage | Buy (N/A) |
55.58 (4.41) |
-92.07% | Details | |
| 3/2/2021 | Ultragenyx Pharma | RARE | New Coverage | Buy (N/A) |
141.54 (21.25) |
-84.99% | Details | |
| 3/2/2021 | ChemoCentryx | CCXI | New Coverage | Buy (N/A) |
67.84 (10.16) |
-85.02% | Details |
